Skip to main content


Landmark ruling strikes down CMA decision on excessive and unfair pricing

Client briefing on the Competition Appeal Tribunal's judgment on the appeals by Pfizer and Flynn against the CMA decision fining them for abusing their dominant positions.

Full text of the briefing in the link below. 

Client briefing
(PDF - 637.1 KB)

Download PDF